Nanoscale drug delivery for targeted chemotherapy
- PMID: 27235607
- DOI: 10.1016/j.canlet.2016.05.023
Nanoscale drug delivery for targeted chemotherapy
Abstract
Despite significant improvements in diagnostic methods and innovations in therapies for specific cancers, effective treatments for neoplastic diseases still represent major challenges. Nanotechnology as an emerging technology has been widely used in many fields and also provides a new opportunity for the targeted delivery of cancer drugs. Nanoscale delivery of chemotherapy drugs to the tumor site is highly desirable. Recent studies have shown that nanoscale drug delivery systems not only have the ability to destroy cancer cells but may also be carriers for chemotherapy drugs. Some studies have demonstrated that delivery of chemotherapy via nanoscale carriers has greater therapeutic benefit than either treatment modality alone. In this review, novel approaches to nanoscale delivery of chemotherapy are described and recent progress in this field is discussed.
Keywords: Cancer therapy; Chemotherapy; Drug delivery system; Nanotechnology.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23. Eur J Pharm Biopharm. 2015. PMID: 25813885 Review.
-
Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system.Arch Pharm Res. 2014 Jan;37(1):4-15. doi: 10.1007/s12272-013-0276-2. Epub 2013 Nov 23. Arch Pharm Res. 2014. PMID: 24272889 Review.
-
Nanomedicine: An effective tool in cancer therapy.Int J Pharm. 2018 Apr 5;540(1-2):132-149. doi: 10.1016/j.ijpharm.2018.02.007. Epub 2018 Feb 7. Int J Pharm. 2018. PMID: 29427746 Review.
-
Nanoscale particulate systems for multidrug delivery: towards improved combination chemotherapy.Ther Deliv. 2014 Feb;5(2):149-71. doi: 10.4155/tde.13.149. Ther Deliv. 2014. PMID: 24483194 Review.
-
Drug delivery systems using polymer nanoassemblies for cancer treatment.Ther Deliv. 2010 Sep;1(3):361-3. doi: 10.4155/tde.10.28. Ther Deliv. 2010. PMID: 22816139 No abstract available.
Cited by
-
GDC-0326 Enhances the Effects of 5-Fu in Colorectal Cancer Cells by Inducing Necroptotic Death.Onco Targets Ther. 2021 Apr 13;14:2519-2530. doi: 10.2147/OTT.S302334. eCollection 2021. Onco Targets Ther. 2021. PMID: 33880032 Free PMC article.
-
The influence of nanocarrier architectures on antitumor efficacy of docetaxel nanoparticles.RSC Adv. 2020 Mar 17;10(19):11074-11078. doi: 10.1039/d0ra01421d. eCollection 2020 Mar 16. RSC Adv. 2020. PMID: 35495347 Free PMC article.
-
Nanosized drug delivery strategies in osteosarcoma chemotherapy.APL Bioeng. 2023 Feb 23;7(1):011501. doi: 10.1063/5.0137026. eCollection 2023 Mar. APL Bioeng. 2023. PMID: 36845905 Free PMC article. Review.
-
Magnetic polymeric nanoassemblies for magnetic resonance imaging-combined cancer theranostics.Int J Nanomedicine. 2018 Jul 23;13:4263-4281. doi: 10.2147/IJN.S164817. eCollection 2018. Int J Nanomedicine. 2018. PMID: 30087559 Free PMC article. Review.
-
Cholesterol-Based Nanovesicles Enhance the In Vitro Cytotoxicity, Ex Vivo Intestinal Absorption, and In Vivo Bioavailability of Flutamide.Pharmaceutics. 2021 Oct 20;13(11):1741. doi: 10.3390/pharmaceutics13111741. Pharmaceutics. 2021. PMID: 34834155 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases